Centrient Pharmaceuticals is a significant business-to-business manufacturer of foundational medicines, including antibiotics, next-generation statins, and anti-fungals. Established in 1869, the company focuses on innovative and sustainable manufacturing to improve lives. With a workforce of 1,800 and operations across four continents, Centrient produces a diverse range of intermediates and active pharmaceutical ingredients (APIs), as well as made-to-order tablets and capsules. The company is transitioning from a traditional manufacturer to an innovation partner, continuously diversifying its portfolio and enhancing its biotechnology capabilities to meet the evolving healthcare needs.
Something looks off?